WPI Chemical Engineer Receives Grants Totaling More than $2M to Speed, Ease Genetic Engineering

“It is essential that manufacturing processes are improved, in order to speed the development of treatments for people with life-threatening genetic diseases.” Worcester Polytechnic Institute chemical engineer Eric Young has...

Read More

LivOnyx: Can you kill a pathogen in three seconds?

The COVID-19 pandemic has placed a hyper-focus on hygiene and infection prevention. For LivOnyx, and its President and Co-Founder Carmela Mascio, that focus is at the heart of its mission....

Read More

LEAH Knox Scholars: MLSC funding making experiences for young scientists possible

In the summer of 2019, the MLSC supported the Health Resources in Action’s LEAH (Leaders through Education, Action, & Hope) Knox Scholars Program, an MIT-based biomedical research training program that...

Read More

Broad Institute launches academic-industry cell imaging consortium to speed drug discovery and development

The Imaging Platform at the Broad Institute of MIT and Harvard, together with industry and non-profit partners, has launched a new collaboration to create a massive cell-imaging dataset, displaying more...

Read More

Interns Playing a Vital Role in a Pandemic

Massachusetts is home to countless life sciences companies working to accelerate the commercialization of promising treatments, therapies, and cures that will improve patient care.  Kephera Diagnostics is one of these...

Read More

Massachusetts manufacturers respond to COVID-19

The Manufacturing Emergency Response Team (M-ERT) is a coordinated response by the Baker-Polito Administration and leading academic and industry stakeholders to support the Commonwealth’s manufacturers in their efforts to produce...

Read More

FDA and Health Canada approve Thermedical’s Degassed Saline to help reduce risk of stroke

Health Canada and the U.S. Food & Drug Administration (FDA) approved Thermedical’s degassed saline for use with its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter, currently being studied...

Read More

Akili announces FDA clearance of EndeavorRx™ for children with ADHD

Akili Interactive announced this week that the FDA has granted clearance for the company’s EndeavorRx as a prescription treatment for children with attention-deficit/hyperactivity disorder (ADHD). Delivered through a captivating video...

Read More